Kathrin Ungethüm
M.Sc. Kathrin Ungethüm
Josef-Schneider-Str. 2
Telefon:
+49 931-201 47342
Fax:
+49 931-201 623104
E-Mail:
ungethuem_k@ukw.de
kurzer Lebenslauf
seit 2018 | Wissenschaftliche Mitarbeiterin, Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg |
2015-2017 | Studium der Epidemiologie (Master of Science) an der Ludwig-Maximilians-Universität München |
2011-2015 | Studium der Humanbiologie (Bachelor of Science) an der Ernst-Moritz-Arndt Universität Greifswald |
wissenschaftliche Schwerpunkte
Versorgungsforschung
Hauptpublikationen der letzten Jahre
2024[ to top ]
-
Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke. Eur Stroke J. 2024;:23969873241234436..
- [ DOI ]
-
Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies. Eur Stroke J. 2024;:23969873241250272..
- [ DOI ]
2023[ to top ]
-
Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys. Clin Res Cardiol. 2023;112(2):285-98..
- [ DOI ]
-
Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design. EClinicalMedicine. 2023;65:102260..
- [ DOI ]
2022[ to top ]
-
Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190..
- [ DOI ]
-
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet Journal of Rare Diseases [Internet]. 2022;17(1):47. Available from: https://doi.org/10.1186/s13023-022-02176-1.
- [ DOI ]
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries. Nature [Internet]. 2022;612(7938):E7-E7. Available from: https://doi.org/10.1038/s41586-022-05492-5.
- [ DOI ]
-
Cardiac dysfunction and high-sensitive C-reactive protein are associated with troponin T elevation in ischemic stroke: insights from the SICFAIL study. BMC Neurology [Internet]. 2022;22(1):511. Available from: https://doi.org/10.1186/s12883-022-03017-1.
- [ DOI ]
-
The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022;37(8):849-70..
- [ DOI ]
2021[ to top ]
-
Feasibility of platelet marker analysis in ischemic stroke patients and their association with one-year outcome. A pilot project within a subsample of the Stroke Induced Cardiac Failure in Mice and Men (SICFAIL) cohort study. Platelets [Internet]. 2021;33(5):772-80. Available from: https://doi.org/10.1080/09537104.2021.2002834.
- [ DOI ]
-
Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8..
- [ DOI ]
-
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review. Stroke. 2021;52(2):543-51..
- [ DOI ]
-
Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study. ESC Heart Failure [Internet]. 2021;8(2):1117-29. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.13145.
- [ DOI ]